Lexaria Bioscience Corp. Net Income Loss

• Lexaria Bioscience Corp. showed a decrease of -105.4% in Net Income Loss from 2024 to 2025.
• This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
• XBRL data for this metric is available from 2010 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 14 years of available data (2010 to 2025), Lexaria Bioscience Corp.'s Net Income Loss has declined by 2,054.3%.
• Historical annual values: Fiscal year 2025: -$11.90 million | Fiscal year 2024: -$5.80 million | Fiscal year 2023: -$6.66 million | Fiscal year 2022: -$7.27 million | Fiscal year 2021: -$4.03 million | Fiscal year 2020: -$4.08 million | Fiscal year 2019: -$4.16 million | Fiscal year 2018: -$6.61 million | Fiscal year 2017: -$1.93 million | Fiscal year 2016: -$1.28 million | Fiscal year 2015: -$1.98 million | Fiscal year 2014: -$1.56 million | Fiscal year 2011: -$538.2 thousand | Fiscal year 2010: -$552.5 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026